GSK: Committed to improving UK clinical research
October 6, 2009Research and Development GSK, GlaxoSmithKline, NHS
GSK is the second biggest pharma company in the world, and Britain’s biggest homegrown firm in the sector. That means …
Contract research news in brief
October 6, 2009Research and Development CRO
Pharmafocus' periodic round-up of developments in the contract research sector includes contracts awarded to Inclinix, Foranep and Phase Forward and …
China to slash medicines prices in October
October 6, 2009Sales and Marketing China, hc, price cuts, prices
The Chinese government has announced it will cut the prices of more than 2,300 drugs by an average of 12% …
Merck wins family business award for excellence
October 5, 2009Sales and Marketing Merck
The oldest global pharma company Merck has received a Family Business Excellence Award, after impressing judges with the 12 generations …
AZ signs biomarker research deal
October 5, 2009Research and Development AZ, Cancer
A deal between AstraZeneca and Cancer Research UK is set to expand biomarker research into how new drugs behave in …
Cervarix not to blame for UK post-vaccination death
October 5, 2009Sales and Marketing Cervarix, NHS, reg, vaccines
The death of a 14-year-old girl who died shortly after having received a cervical cancer vaccine was caused by an …
Baxter’s H1N1 vaccine set for European licence
October 5, 2009Sales and Marketing baxter, h1n1
Baxter’s swine-flu vaccine is third in line for approval in Europe, behind already approved rivals from GSK and Novartis.Regulatory advisors …
Sanofi says its H1N1 jab effective after one dose
October 2, 2009Sales and Marketing Sanofi, h1n1
Sanofi Pasteur, the vaccines division of the Sanofi-Aventis Group, has said its swine flu vaccine is effective after a single …
FDA streamlines GMP for combination products
October 2, 2009Manufacturing and Production FDA, US, reg
The US Food and Drug Administration has said it will draw up new rules on Good Manufacturing Practices (GMP) for …
UK children recruited for H1N1 vaccine trials
October 2, 2009Research and Development, Sales and Marketing h1n1, paediatric, vaccines
The UK has commenced a two-week swine flu vaccine trial, a month ahead of its planned programme to vaccinate 11 …
Netherlands ranked as top healthcare system
October 2, 2009Sales and Marketing Netherlands, hc
The Netherlands has come out top for the second year in a row in a pan-European survey of healthcare systems. …
Janssen-Cilag and Novartis take top digital prizes
October 2, 2009Medical Communications PM Soc, PM Society Digital Awards, awards, digi, pm society
Top prizes at the PM Society’s inaugural Digital Media Awards last night went to Janssen-Cilag and Novartis.Work on Janssen-Cilag’s Concerta …
Athena promotes Tania Kouprach-Rolandi and appoints Dr Sabah Al-Lawati
October 1, 2009Medical Communications Athena, appointment, medical communications
Athena has promoted Tania Kouprach-Rolandi to senior account manager and appointed Dr Sabah Al-Lawati as an account director for medical …
MedeConnect Healthcare Insight appoints Nicky Richards and Neil Reynolds
October 1, 2009Sales and Marketing appointment, medeconnect, sales and marketing
MedeConnect Healthcare Insight, the market research division of Doctors.net.uk, has announced the appointment of two client services directors: Nicky Richards, …
Marilyn Ewan, account director, Fleishman-Hillard
October 1, 2009Medical Communications Fleishman, appointment, medical communications
Fleishman-Hillard Group has appointed Marilyn Ewan as an account director in its healthcare division.Marilyn brings all-round account handling experience to …
Europe warns pharma about further competition probes
October 1, 2009Sales and Marketing EU, antitrust investigation, reg
The European Commission has warned the industry a new round of antitrust probes will be coming soon, just as the …
Sanofi-Aventis acquires French biotech Fovea
October 1, 2009Sales and Marketing Sanofi, ophth
Sanofi-Aventis is to acquire Fovea Pharmaceuticals, a privately held French company with a focus on diseases of the eye.Fovea has …
New 2-in-1 Valturna outperforms Diovan
October 1, 2009Sales and Marketing Diovan, Novartis, Tekturna, cv, hyp, hypertension
Novartis has gained US approval for a combination of its blockbuster blood pressure drug Diovan and its follow-up product Tekturna/Rasilez.Valturna …
Marketers: get more bang for your buck
October 1, 2009Medical Communications MSI, marketing
Pharma marketing is under increasing pressure to demonstrate how it adds value, especially when it comes to justifying expenditure. Brand …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
